Article
Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5).
Blood - 21 Jun 2012
Pagel Julia, Beutel Karin, Lehmberg Kai, Koch Florian, Maul-Pavicic Andrea, Rohlfs Anna-Katharina, Al-Jefri Abdullah, Beier Rita, Bomme Ousager Lilian, Ehlert Karoline, Gross-Wieltsch Ute, Jorch Norbert, Kremens Bernhard, Pekrun Arnulf, Sparber-Sauer Monika, Mejstrikova Ester, Wawer Angela, Ehl Stephan, zur Stadt Udo, Janka Gritta
Abstract excerpt
Familial hemophagocytic lymphohistiocytosis (FHL) is a genetically determined hyperinflammatory syndrome caused by uncontrolled immune response mediated by T-lymphocytes, natural killer (NK) cells, and macrophages. STXBP2 mutations have recently been associated with FHL5. To better characterize the genetic and clinical spectrum of FHL5, we analyzed a cohort of 185 patients with suspected FHL for mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
